Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Barrett

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Biopharmaceutics & Drug Disposition|March 1, 1997
Toxicokinetic evaluation of a selegiline transdermal system in the dogJ S Barrett, A R DiSanto, P J Thomford, et al.
Lipids in Health and Disease|April 2, 2024
GLUT4 localisation with the plasma membrane is unaffected by an increase in plasma free fatty acid availabilityJ S Barrett, J A Strauss, L S Chow, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2001
Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosisJ S Barrett, E Gibiansky, R D Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6B J Gertz, J S Barrett, R Eisenhandler, et al.
American Journal of Therapeutics|October 1, 1996
Pharmacokinetics and safety of a selegiline transdermal system relative to single-dose oral administration in the elderlyJ S Barrett, T J Hochadel, R J Morales, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 15, 2001
Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin in healthy volunteersM J Fossler, J S Barrett, J W Hainer, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|February 22, 2011
Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cerealsJ R Biesiekierski, O Rosella, R Rose, et al.
Physical Review Letters|May 3, 2014
Measurement of the survival probabilities for hot fusion reactionsR Yanez, W Loveland, L Yao, et al.
Clinical Pharmacology and Therapeutics|October 1, 1994
Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy menJ S Barrett, G Murphy, K Peerlinck, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2010
Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumorsT Kimura, S Kashiwase, A Makimoto, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Biopharmaceutics & Drug Disposition|March 1, 1997
Toxicokinetic evaluation of a selegiline transdermal system in the dogJ S Barrett, A R DiSanto, P J Thomford, et al.
Lipids in Health and Disease|April 2, 2024
GLUT4 localisation with the plasma membrane is unaffected by an increase in plasma free fatty acid availabilityJ S Barrett, J A Strauss, L S Chow, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2001
Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosisJ S Barrett, E Gibiansky, R D Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6B J Gertz, J S Barrett, R Eisenhandler, et al.
American Journal of Therapeutics|October 1, 1996
Pharmacokinetics and safety of a selegiline transdermal system relative to single-dose oral administration in the elderlyJ S Barrett, T J Hochadel, R J Morales, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 15, 2001
Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin in healthy volunteersM J Fossler, J S Barrett, J W Hainer, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|February 22, 2011
Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cerealsJ R Biesiekierski, O Rosella, R Rose, et al.
Physical Review Letters|May 3, 2014
Measurement of the survival probabilities for hot fusion reactionsR Yanez, W Loveland, L Yao, et al.
Clinical Pharmacology and Therapeutics|October 1, 1994
Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy menJ S Barrett, G Murphy, K Peerlinck, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2010
Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumorsT Kimura, S Kashiwase, A Makimoto, et al.
Pageof 7